COMMUNIQUÉS West-GlobeNewswire

ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024
23/04/2024
SOLANA BEACH, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine [...]
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
23/04/2024
REDWOOD CITY, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial [...]
Pennant Announces First Quarter 2024 Earnings Release and Call
23/04/2024
EAGLE, Idaho, April 23, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
23/04/2024
First and only FDA-approved type II RAF inhibitor for patients with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation RAPNO LGG overall response rate (ORR) of 51% Day One [...]
OrthoSelect announces Partnership with Relu to provide automated CBCT integration for DIBS AI software
23/04/2024
AMERICAN FORK, Utah, April 23, 2024 (GLOBE NEWSWIRE) -- OrthoSelect, a leading orthodontics software company and digital orthodontics laboratory, announces a partnership with Belgium-based Relu to integrate the award- [...]
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
23/04/2024
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and adult patients Gastroenteropancreatic neuroendocrine tumors ( [...]
Grant of warrants
23/04/2024
23 April 2024 Announcement no. 9 Grant of Warrants COPENHAGEN, DENMARK and BOSTON, MA, USA, April 23, 2024 (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR) has [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mars 2024
23/04/2024
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mars 2024 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les [...]
SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024
23/04/2024
BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the [...]
Survey: Physicians Turning to Locum Tenens to Improve Work Conditions, Relieve Burnout
23/04/2024
Many Would Return to Permanent Positions If Conditions Right DALLAS, April 23, 2024 (GLOBE NEWSWIRE) -- Physicians and advanced practice professionals are opting for the flexibility of temporary, “locum tenens” work in [...]
HealthSource of Ohio names Jody Prather, MD, as its President and CEO
23/04/2024
CINCINNATI, April 23, 2024 (GLOBE NEWSWIRE) -- HealthSource of Ohio announced today the appointment of Jody Prather, MD as its next President and Chief Executive Officer following an extensive, nationwide search process [...]
Epic Bio Presents New Data Highlighting Potential of EPI-321 for FSHD and Epigenetic Editing Platform Leadership at ASGCT Annual Meeting
23/04/2024
- Across robust slate of presentations, company highlights compelling new data and strong differentiation - SOUTH SAN FRANCISCO, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Epic Bio , a leading epigenetic editing company [...]
Visory Health Secures Women’s Business Enterprise National Council Certification for Third Consecutive Year
23/04/2024
The Florida-based, woman-owned business granting accessible, affordable prescriptions to underserved populations joins 18,000 other prestigious female-led companies after rigorous vetting ESTERO, Fla., April 23, 2024 ( [...]
Viemed Healthcare Announces Date and Time for Conference Call
23/04/2024
LAFAYETTE, La., April 23, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “ Company ” or “ Viemed ”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, [...]
NeurAxis Announces New Medical Policy Coverage in North Dakota
23/04/2024
CARMEL, Ind., April 23, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]
Mobile-health Network and Online Pharmacy, Lifepack, Sign Partnership Facilitating Cooperation in Singapore and Indonesia
23/04/2024
SINGAPORE, April 23, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or the “Company”), a pioneering Asia-Pacific (“APAC”) telehealth provider, has announced a strategic partnership [...]
ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call
23/04/2024
SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter [...]
Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
23/04/2024
IRVINE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for [...]
STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024
23/04/2024
HORSHAM, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]

Pages